How The Laser Masters is Changing Healthcare with Laser Therapy
Photo Courtesy: Dr. Robert Hanopole and Dr. Michael Rubenstein / The Laser Masters

How The Laser Masters is Changing Healthcare with Laser Therapy

By: Alena Wiese 

In an era where healthcare is often dictated by insurance red tape, shrinking reimbursements, and rising costs, Dr. Robert Hanopole and Dr. Michael Rubenstein have built a transformative alternative that is profitable, patient-centric, and poised to change the landscape of non-invasive pain management.

As the co-founders of The Laser Masters and developers of the ReliefNow® Laser Methods, Hanopole and Rubenstein present a scalable, cash-based business model designed to help medical professionals reduce reliance on insurance while incorporating Class IV deep tissue laser therapy for pain relief.

Their business model is highlighted as a case study in Beyond the Beam: Leveraging Regenerative Laser Therapy for Business Success, a book co-authored by Dr. Tamara “Tami” Patzer and Paul Schweet.

A Business Model That Challenges the Status Quo in Healthcare

The U.S. healthcare system has long been dominated by insurance-controlled treatment plans, forcing practitioners to navigate complex billing processes while struggling to provide optimal patient care. The system frustrates doctors, patients, underserved, and businesses working to remain profitable.

Seeing this challenge, Hanopole and Rubenstein developed The Laser Masters model, a turnkey solution for doctors, chiropractors, and physical therapists that:

  • Allowing providers to operate cash-based clinics where patients pay directly for laser therapy sessions creates an alternative revenue model.
  • Increases patient retention and lifetime value by allowing practitioners to offer highly effective, non-invasive pain relief solutions, improving patient satisfaction and repeat visits.
  • Offers a structured model for growth, including marketing support, operational systems, and ongoing training.

“Doctors don’t realize they can be incredibly successful while running an insurance-free practice,” Hanopole said. “The Laser Masters system gives them everything they need to build a thriving business while focusing on patient care—not paperwork.”

Regenerative Laser Therapy: An Emerging Approach to Pain Management

Interest in regenerative medicine is growing as patients explore alternatives to surgery and pharmaceuticals. The FDA-cleared Class IV deep tissue laser therapy offered through The Laser Masters has been studied for its potential to:

  • Reduce inflammation and improve circulation.
  • Accelerate recovery from injuries and chronic pain conditions.
  • Provide lasting pain relief without the risks of opioids or surgery.

Unlike traditional pain management approaches, laser therapy harnesses light energy to stimulate cellular repair, promoting natural healing at a faster rate.

“This isn’t just another treatment option—it’s a medical revolution,” Rubenstein said. “We’re helping practitioners bring cutting-edge technology to their patients while increasing business profitability.”

From Notable Book to Business Guide: Beyond the Beam

The Laser Masters has been featured in Beyond the Beam: Leveraging Regenerative Laser Therapy for Business Success, a book that has ranked on multiple Amazon category charts, including:

  • Number one best seller in Lasers in Medicine
  • Number one hot new release in Business Franchises
  • Number one hot new release in Healthcare Management

The book details how Hanopole and Rubenstein built a sustainable, scalable business model that empowers healthcare entrepreneurs to integrate Class IV laser therapy into their practices and scale their businesses effectively.

“We wanted to share our success formula with practitioners across the country,” said Schweet, a leading healthcare business consultant and co-author of the book. “This isn’t just about better treatments—it’s about creating financial freedom for doctors while improving patient care.”

A Mission Beyond Business: The Ditch the Drugs and Skip the Scalpel®

Hanopole, Rubenstein, and Schweet are working to support doctors in business while advocating for alternative approaches in healthcare.

Through the Ditch the Drugs  and Skip the Scalpel™ Foundation, they aim to:

  • Educate patients and medical professionals about the dangers of opioid dependency and the overuse of surgical interventions.
  • Expand access to regenerative laser therapy for patients in need.
  • Train and certify medical professionals in the latest non-invasive pain management techniques.

“Our foundation is about more than just business—it’s about leaving a legacy of change in healthcare,” Hanopole said. “We want patients to know that surgery and opioids are not their only options.”

The Future of Regenerative Healthcare Is Here

With The Laser Masters, the ReliefNow® Laser Methods, and their influence in business and healthcare innovation, Hanopole and Rubenstein are leading a new wave of medical entrepreneurship.

Their inclusion in Beyond the Beam contributes to the conversation around regenerative laser therapy, highlighting how healthcare can balance patient-centered care with financial sustainability for practitioners.

Where to Get Beyond the Beam

Beyond the Beam: Leveraging Regenerative Laser Therapy for Business Success is available now on Amazon.

For more information on The Laser Masters, the ReliefNow® Laser Methods, or unfranchise opportunities, visit TheLaserMasters.com.

About Dr. Robert Hanopole and Dr. Michael Rubenstein

Dr. Robert Hanopole and Dr. Michael Rubenstein are the co-founders of The Laser Masters, developers of the ReliefNow® Laser Methods, and leading experts in Class IV deep tissue laser therapy. They have worked with numerous practitioners to establish insurance-free practices using their structured business model. As co-founders of the Ditch the Drugs and Skip the Scalpel® Foundation, they support awareness efforts for opioid-free pain management solutions.

Published by Tom W.

(Ambassador)

This article features branded content from a third party. Opinions in this article do not reflect the opinions and beliefs of New York Weekly.